Screening and genetic diagnosis of haemoglobin disorders.

The inherited haemoglobinopathies are large group of disorders that include the thalassaemias and sickle cell disease. Carrier detection methods must be able to detect alpha-, beta- and deltabeta-thalassaemias, HPFH disorders and haemoglobin variants. Carrier diagnosis involves the accurate measurement of MCH, MCV, Hb A(2) and Hb F values in combination with an understanding of the haematological characteristics of the different types of thalassaemia genes and their interactions. The majority of the common thalassaemia mutations and abnormal haemoglobins can be identified by PCR-based techniques. The main applications of molecular analysis for carrier diagnosis are: the analysis of alpha-thalassaemia mutations by gap-PCR to discriminate between heterozygous alpha-thalassaemia and homozygous alpha-thalassaemia; the identification of beta-thalassaemia mutations for patients requiring prenatal diagnosis and for the prediction of the severity of the clinical phenotype of homozygous beta-thalassaemia; to discriminate between deltabeta-thalassaemia and HPFH deletions by gap-PCR.

[1]  D. Higgs,et al.  Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia , 2000 .

[2]  T. Ko,et al.  Prenatal diagnosis of Hb H disease due to compound heterozygosity for South‐East Asian deletion and Hb constant spring by polymerase chain reaction , 1993, Prenatal diagnosis.

[3]  H A Erlich,et al.  Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Chih‐Peng Chang,et al.  Rapid diagnosis of β‐thalassaemia by mutagenically separated polymerase chain reaction (MS‐PCR) and its application to prenatal diagnosis , 1995, British journal of haematology.

[5]  A. Schechter,et al.  Genetic diseases of hemoglobin: diagnostic methods for elucidating beta-thalassemia mutations. , 2001, Blood reviews.

[6]  S. Thein 3 β-Thalassaemia , 1998 .

[7]  R. Fodde,et al.  Denaturing gradient gel electrophoresis and direct sequencing of PCR amplified genomic DNA: a rapid and reliable diagnostic approach to beta thalassaemia , 1990, British journal of haematology.

[8]  D. Weatherall,et al.  Direct detection of haemoglobin E with MnlI. , 1987, Journal of medical genetics.

[9]  J. Tay,et al.  The amplification refractory mutation system (ARMS): A rapid and direct prenatal diagnostic technique for β‐thalassaemia in Singapore , 1994 .

[10]  D. Weatherall,et al.  Rapid detection and prenatal diagnosis of β-thalassaemia: studies in Indian and Cypriot populations in the UK , 1990, The Lancet.

[11]  A. Cao,et al.  A simple electrophoretic procedure for fetal diagnosis of β‐thalassaemia due to short deletions , 1992, Prenatal diagnosis.

[12]  J. Craig,et al.  Molecular characterization of a novel 10.3 kb deletion causing β‐thalassaemia with unusually high Hb A2 , 1992, British journal of haematology.

[13]  J. Milunsky,et al.  Genetic Disorders and the Fetus , 1988 .

[14]  R. Saiki,et al.  Reverse dot‐blot detection of Thai β‐thalassaemia mutations , 1995 .

[15]  R. Barnetson,et al.  Rapid detection of deletions causing delta beta thalassemia and hereditary persistence of fetal hemoglobin by enzymatic amplification. , 1994, Blood.

[16]  E. Baysal,et al.  Detection of common deletional α‐thalassemia‐2 determinants by PCR , 1994 .

[17]  D. Higgs,et al.  A PCR‐based strategy to detect the common severe determinants of α thalassaemia , 1992 .

[18]  M. Losekoot,et al.  Rapid detection of point mutations and polymorphisms of the α‐globin genes by DGGE and SSCA , 1996 .

[19]  J. Clegg,et al.  Molecular basis for dominantly inherited inclusion body beta-thalassemia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Clegg,et al.  Rapid detection of α‐thalassaemia deletions and α‐globin gene triplication by multiplex polymerase chain reactions , 2000, British journal of haematology.

[21]  A. Kutlar,et al.  A C----T substitution at nt--101 in a conserved DNA sequence of the promotor region of the beta-globin gene is associated with "silent" beta-thalassemia. , 1989, Blood.

[22]  D. Chui,et al.  High hemoglobin A2 beta 0-thalassemia due to a 532-basepair deletion of the 5' beta-globin gene region. , 1991, Blood.

[23]  H. Hwa,et al.  Erratum: Molecular characterization and PCR diagnosis of Thailand deletion of α-globin gene cluster (American Journal of Hematology (1998) (124-130)) , 1999 .

[24]  R. Saiki,et al.  Reverse dot-blot detection of the African-American beta-thalassemia mutations. , 1995, Blood.

[25]  D. Weatherall,et al.  Molecular characterization of a high A2 beta thalassemia by direct sequencing of single strand enriched amplified genomic DNA. , 1989, Blood.

[26]  R. Lindeman,et al.  Polymerase chain reaction (PCR) mutagenesis enabling rapid non‐radioactive detection of common β‐thalassaemia mutations in Mediterraneans , 1991, British journal of haematology.

[27]  R. Saiki,et al.  Prenatal diagnosis of β‐thalassaemia in Mediterranean populations by dot blot analysis with DNA amplification and allele specific oligonucleotide probes , 1989, Prenatal diagnosis.

[28]  J. Old Prenatal Diagnosis of the Hemoglobinopathies , 1986, Genetic Disorders and the Fetus.

[29]  J. B. Clegg,et al.  The thalassaemia syndromes , 1965 .

[30]  F. Chehab,et al.  Detection of specific DNA sequences by fluorescence amplification: a color complementation assay. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Chui,et al.  Filipino β-thalassemia due to a large deletion: identification of the deletion end points and polymerase chain reaction (PCR)-based diagnosis , 1994, Human Genetics.

[32]  A. Dimovski,et al.  A β°‐thalassaernia due to a 1605 bp deletion of the 5‘β‐globin gene region , 1993 .

[33]  J. Bidwell,et al.  Detection of β‐thalassaemia mutations using DNA heteroduplex generator molecules , 1995 .

[34]  D. Weatherall,et al.  Characterization of the breakpoint of a 3.5-kb deletion of the β-globin gene , 1991 .

[35]  Jeffrey D. Wall,et al.  Rapid and simultaneous typing of hemoglobin S, hemoglobin C, and seven Mediterranean beta-thalassemia mutations by covalent reverse dot-blot analysis: application to prenatal diagnosis in Sicily. , 1993, Blood.

[36]  Y. Postnikov,et al.  A simplified procedure for sequencing amplified DNA containing the α2- or α1-Globin gene , 1994 .